Narayana Hrudayalaya Limited (BOM: 539551)
India
· Delayed Price · Currency is INR | Market Cap | 261.61B |
| Revenue (ttm) | 52.21B |
| Net Income (ttm) | 7.79B |
| Shares Out | n/a |
| EPS (ttm) | 38.35 |
| PE Ratio | 33.59 |
| Forward PE | n/a |
| Dividend | 4.00 (0.31%) |
| Ex-Dividend Date | Aug 2, 2024 |
| Volume | 26,314 |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | 1,087.80 - 1,445.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 5, 2025 |
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology se... [Read more]
Financial Performance
In 2023, Narayana Hrudayalaya's revenue was 50.18 billion, an increase of 10.79% compared to the previous year's 45.30 billion. Earnings were 7.89 billion, an increase of 30.19%.
Financial StatementsNews
Stocks in focus: Tata Invest, Narayana Hrudayalaya, BF Utilities, Sudarshan Pharma and others set to announce Q2 FY24-25 results today
A series of key financial results for the quarter ending September 2024 are expected today from several companies. Notable among them are Tata Investment Corporation and Narayana Hrudayalaya, whose fi...